![Andreas Norlin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Andreas Norlin
Technik-/Wissenschafts-/F&E-Leiter bei ASCELIA PHARMA AB
Vermögen: 12 367 $ am 31.05.2024
Profil
Andreas L.
Norlin is the founder of Xkout Bioscience AB.
He is currently working as a Director at ApoGlyx AB and Desupervised ApS.
Additionally, he is serving as the Chief Scientific Officer at Ascelia Pharma AB since 2020.
Dr. Norlin has a graduate and doctorate degree from the University of Lund.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
ASCELIA PHARMA AB
0,04% | 13.07.2023 | 12 364 ( 0,04% ) | 12 367 $ | 31.05.2024 |
Aktive Positionen von Andreas Norlin
Unternehmen | Position | Beginn |
---|---|---|
ASCELIA PHARMA AB | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2020 |
ApoGlyx AB
![]() ApoGlyx AB BiotechnologyHealth Technology ApoGlyx AB engages in research and development of aquaporin inhibitors. It conducts sales of know-how, licenses, and chemical substance in biochemistry. The company was founded by Per Ola Kjellbom on April 22, 2008 and is headquartered in Lund, Sweden. | Direktor/Vorstandsmitglied | - |
Desupervised ApS
![]() Desupervised ApS Information Technology ServicesTechnology Services Part of Hamiltonian Holding ApS, Desupervised ApS is a Danish company that provides artificial intelligence software services. The company is based in Copenhagen, Denmark. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Andreas Norlin
Unternehmen | Position | Ende |
---|---|---|
Xkout Bioscience AB | Gründer | - |
Ausbildung von Andreas Norlin
University of Lund | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ASCELIA PHARMA AB | Health Technology |
Private Unternehmen | 3 |
---|---|
ApoGlyx AB
![]() ApoGlyx AB BiotechnologyHealth Technology ApoGlyx AB engages in research and development of aquaporin inhibitors. It conducts sales of know-how, licenses, and chemical substance in biochemistry. The company was founded by Per Ola Kjellbom on April 22, 2008 and is headquartered in Lund, Sweden. | Health Technology |
Xkout Bioscience AB | |
Desupervised ApS
![]() Desupervised ApS Information Technology ServicesTechnology Services Part of Hamiltonian Holding ApS, Desupervised ApS is a Danish company that provides artificial intelligence software services. The company is based in Copenhagen, Denmark. | Technology Services |